Aptose Biosciences Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aptose Biosciences Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Aptose Biosciences Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$6.95M, a 39.3% increase year-over-year.
  • Aptose Biosciences Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$35.8M, a 27.3% increase year-over-year.
  • Aptose Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$51.2M, a 22.4% decline from 2022.
  • Aptose Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$41.8M, a 36% increase from 2021.
  • Aptose Biosciences Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$65.4M, a 18.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$51.2M -$9.38M -22.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 -$41.8M +$23.5M +36% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 -$65.4M -$10.1M -18.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$55.2M -$29M -110% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$26.3M +$2.59M +8.98% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 -$28.9M -$17.2M -148% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 -$11.6M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.